Skip to main content
Erschienen in: Pituitary 2/2017

12.10.2016

Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia

verfasst von: Benita Tamrazi, Melike Pekmezci, Mariam Aboian, Tarik Tihan, Christine M. Glastonbury

Erschienen in: Pituitary | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Rationale and objectives

Pituitary macroadenomas are predominantly benign intracranial neoplasms that can be locally aggressive with invasion of adjacent structures. Biomarkers of aggressive behavior have been identified in the pathology literature, including the proliferative marker MIB-1. In the radiology literature, diffusion weighted imaging and low ADC values provide similar markers of aggressive behavior in brain tumors. The purpose of this study was to determine if there is a correlation between ADC and MIB-1 in pituitary macroadenomas.

Materials and methods

A retrospective review of diffusion imaging and immunohistochemical characteristics of pituitary macroadenomas was performed. The ADC ratio and specimen Ki-67 (MIB-1) indices were measured. Linear regression analysis of normalized ADC values and MIB-1 indices was used to compare these parameters.

Results

There were 17 patients with available ADC maps and MIB-1 indices. Local invasion was confirmed by imaging and intraoperative visualization in 11 patients. The mean ADC ratio for the invasive group was 0.68, with a mean MIB-1 index of 2.21 %. In the noninvasive group, the mean ADC ratio was 1.05, with a mean MIB-1 index of 0.9 %. Linear regression analysis of normalized ADC values versus MIB-1 demonstrates a negative correlation, with a linear slope significantly different from zero (p = 0.003, correlation coefficient of 0.77, and r squared = 0.59).

Conclusion

We determine a strong correlation of low ADC values and MIB-1, demonstrating the potential of diffusion imaging as a possible biomarker for atypical, proliferative adenomas, which may ultimately affect the surgical approach and postoperative management.
Literatur
1.
Zurück zum Zitat Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798–827PubMed Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798–827PubMed
2.
Zurück zum Zitat Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systemic review. Cancer 101:613–619CrossRefPubMed Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systemic review. Cancer 101:613–619CrossRefPubMed
3.
Zurück zum Zitat Magagna-Poveda A, Leske H, Schmid C et al (2013) Expression of somatostatin receptors, angiogenesis and proliferation markers in pituitary adenomas: an immunohistochemical study with diagnostic and therapeutic implications. Swiss Med Wkly 143:1–11 Magagna-Poveda A, Leske H, Schmid C et al (2013) Expression of somatostatin receptors, angiogenesis and proliferation markers in pituitary adenomas: an immunohistochemical study with diagnostic and therapeutic implications. Swiss Med Wkly 143:1–11
5.
Zurück zum Zitat Asa SL (2008) Practical pituitary pathology: what does the pathologist need to know. Arch Pathol Lab Med 132:1231–1240PubMed Asa SL (2008) Practical pituitary pathology: what does the pathologist need to know. Arch Pathol Lab Med 132:1231–1240PubMed
6.
Zurück zum Zitat Zada G, Woodmanse WW, Ramkissoon S et al (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336–344CrossRefPubMed Zada G, Woodmanse WW, Ramkissoon S et al (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336–344CrossRefPubMed
8.
Zurück zum Zitat Saeger W, Ludecke DK, Buchfelder M et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203–216CrossRefPubMed Saeger W, Ludecke DK, Buchfelder M et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203–216CrossRefPubMed
9.
Zurück zum Zitat Mete O, Ezzat S, Asa SL (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49:69–78CrossRef Mete O, Ezzat S, Asa SL (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49:69–78CrossRef
10.
Zurück zum Zitat Paek KI, Kim SH, Song SH, Choi SW et al (2005) Clinical significance of Ki-67 labeling index in pituitary macroadenoma. J Korean Med Sci 20:489–494CrossRefPubMedPubMedCentral Paek KI, Kim SH, Song SH, Choi SW et al (2005) Clinical significance of Ki-67 labeling index in pituitary macroadenoma. J Korean Med Sci 20:489–494CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ginat DT, Mangla R, Yeaney G et al (2010) Correlation of diffusion and perfusion MRI with Ki-67 in high grade meningiomas. AJR 195:1391–1395CrossRefPubMed Ginat DT, Mangla R, Yeaney G et al (2010) Correlation of diffusion and perfusion MRI with Ki-67 in high grade meningiomas. AJR 195:1391–1395CrossRefPubMed
12.
Zurück zum Zitat Calvar JA, Meli FJ, Romero C, Calcagno ML et al (2005) Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol 72:273–280CrossRefPubMed Calvar JA, Meli FJ, Romero C, Calcagno ML et al (2005) Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol 72:273–280CrossRefPubMed
13.
Zurück zum Zitat Matsuyama J (2012) Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlations with clinical variables. Neurol Med Chir 52:563–569CrossRef Matsuyama J (2012) Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlations with clinical variables. Neurol Med Chir 52:563–569CrossRef
14.
Zurück zum Zitat Mohamed FF, Abouhashem S (2013) Diagnostic value of apparent diffusion coefficient (ADC) in assessment of pituitary macroadenoma consistency. Egypt J Radiol Nucl Med 44:617–624CrossRef Mohamed FF, Abouhashem S (2013) Diagnostic value of apparent diffusion coefficient (ADC) in assessment of pituitary macroadenoma consistency. Egypt J Radiol Nucl Med 44:617–624CrossRef
15.
Zurück zum Zitat Mahmoud OM, Tominaga A, Amatya VJ, Ohtaki M et al (2011) Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol 80:412–417CrossRefPubMed Mahmoud OM, Tominaga A, Amatya VJ, Ohtaki M et al (2011) Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol 80:412–417CrossRefPubMed
16.
Zurück zum Zitat Sizuki C, Maeda M, Hori K et al (2007) Apparent diffusion coefficient of pituitary macroadenoma evaluated with line scan diffusion weighted imaging. J Neuroradiol 34:228–235CrossRef Sizuki C, Maeda M, Hori K et al (2007) Apparent diffusion coefficient of pituitary macroadenoma evaluated with line scan diffusion weighted imaging. J Neuroradiol 34:228–235CrossRef
17.
Zurück zum Zitat Boxerman JL, Rogg JM, Donahue JE, Machan JT et al (2010) Preoperative MRI evaluation of pituitary macroadenoma: imaging features predictive of successful trans-sphenoidal surgery. AJR 195:720–728CrossRefPubMed Boxerman JL, Rogg JM, Donahue JE, Machan JT et al (2010) Preoperative MRI evaluation of pituitary macroadenoma: imaging features predictive of successful trans-sphenoidal surgery. AJR 195:720–728CrossRefPubMed
18.
Zurück zum Zitat Pierallini A, Caramia F, Falcone C et al (2006) Pituitary macroadenomas: preoperative evaluation of consistency with diffusion weighted MR imaging- initial experience. Radiology 239:223–231CrossRefPubMed Pierallini A, Caramia F, Falcone C et al (2006) Pituitary macroadenomas: preoperative evaluation of consistency with diffusion weighted MR imaging- initial experience. Radiology 239:223–231CrossRefPubMed
19.
Zurück zum Zitat Micko ASG, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with MRI-based classification. JNS 122:803–811 Micko ASG, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with MRI-based classification. JNS 122:803–811
Metadaten
Titel
Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia
verfasst von
Benita Tamrazi
Melike Pekmezci
Mariam Aboian
Tarik Tihan
Christine M. Glastonbury
Publikationsdatum
12.10.2016
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 2/2017
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-016-0759-5

Weitere Artikel der Ausgabe 2/2017

Pituitary 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.